Vaccine trial whistle blower
Covid19: Researcher blows the whistle on data integrity issues in Pfizers vaccine trial, Revelations of poor practices at a contract research company Pfizers pivotal covid19 vaccine trial, raise questions about data integrity and regulatory oversight This was the original paper Autumn 2020 Pfizers chairman and chief executive, Albert Bourla As Ive said before, we are operating at the speed of science Ventavia Research Group Researchers were testing Pfizers vaccine at several sites in Texas A regional director, Brook Jackson has told The BMJ that the company falsified data unblinded patients employed inadequately trained vaccinators was slow to follow up on adverse events reported in Pfizers pivotal phase III trial Staff who conducted quality control checks were overwhelmed by the volume of problems they were finding. US Food and Drug Administration (FDA) w
|
|